Lyell CSO: New job is ‘the missing piece’ of his career; Orphazyme and Cortexyme and Sio, oh my: Your guide to the latest CEO changes

Gary Lee

“I fully recognize that cell therapy is still all about the cells.”

In moving over to his second CSO job, Gary Lee says he hopes to grasp a “really critical” missing piece of the puzzle in cell therapy: T cell biology, something he hadn’t gotten a…